Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experience with International Neuroblastoma Staging System and Pathology Classification.
Ikeda H, Iehara T, Tsuchida Y, Kaneko M, Hata J, Naito H, Iwafuchi M, Ohnuma N, Mugishima H, Toyoda Y, Hamazaki M, Mimaya J, Kondo S, Kawa K, Okada A, Hiyama E, Suita S, Takamatsu H. Ikeda H, et al. Among authors: mimaya j. Br J Cancer. 2002 Apr 8;86(7):1110-6. doi: 10.1038/sj.bjc.6600231. Br J Cancer. 2002. PMID: 11953858 Free PMC article.
Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months.
Kawa K, Ohnuma N, Kaneko M, Yamamoto K, Etoh T, Mugishima H, Ohhira M, Yokoyama J, Bessho F, Honna T, Yoshizawa J, Nakada K, Iwafuchi M, Nozaki T, Mimaya J, Sawada T, Nakamura T, Miyata H, Yamato K, Tsuchida Y. Kawa K, et al. Among authors: mimaya j. J Clin Oncol. 1999 Oct;17(10):3216-20. doi: 10.1200/JCO.1999.17.10.3216. J Clin Oncol. 1999. PMID: 10506621
Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T, Kohno S, Mimaya J, Hasegawa S, Urushihara N, Yoshida A, Kawano S, Kusafuka J, Horikoshi Y, Takashima Y, Aoki K, Hamazaki M. Okazaki T, et al. Among authors: mimaya j. Pediatr Surg Int. 2004 Jan;20(1):27-32. doi: 10.1007/s00383-003-1070-x. Epub 2003 Dec 19. Pediatr Surg Int. 2004. PMID: 14689211
Phase I study of irinotecan in pediatric patients with malignant solid tumors.
Mugishima H, Matsunaga T, Yagi K, Asami K, Mimaya J, Suita S, Kishimoto T, Sawada T, Tsuchida Y, Kaneko M. Mugishima H, et al. Among authors: mimaya j. J Pediatr Hematol Oncol. 2002 Feb;24(2):94-100. doi: 10.1097/00043426-200202000-00007. J Pediatr Hematol Oncol. 2002. PMID: 11990713 Clinical Trial.
Irinotecan for children with relapsed solid tumors.
Shitara T, Shimada A, Hanada R, Matsunaga T, Kawa K, Mugishima H, Sugimoto T, Mimaya J, Manabe A, Tsurusawa M, Tsuchida Y. Shitara T, et al. Among authors: mimaya j. Pediatr Hematol Oncol. 2006 Mar;23(2):103-10. doi: 10.1080/08880010500457152. Pediatr Hematol Oncol. 2006. PMID: 16651238 Clinical Trial.
Hepatoblastoma with congenital absence of the portal vein - a case report.
Kawano S, Hasegawa S, Urushihara N, Okazaki T, Yoshida A, Kusafuka J, Mimaya J, Horikoshi Y, Aoki K, Hamazaki M. Kawano S, et al. Among authors: mimaya j. Eur J Pediatr Surg. 2007 Aug;17(4):292-4. doi: 10.1055/s-2007-965448. Eur J Pediatr Surg. 2007. PMID: 17806031
116 results